Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Glaucoma Clinical Trials

108 recruiting trials for Glaucoma. Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
108
Total Trials
108
Recruiting Now
8
Phase 3 Trials
10
Sponsors

Recruiting Trials

Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.

RECRUITINGPhase 3NCT03933631

Pilocarpine Use After Kahook Goniotomy

The goal of this study is to determine whether using pilocarpine provides added benefit to the success of combined cataract + Kahook Dual Blade (KDB) surgery.

Sponsor: Montefiore Medical CenterEnrolling: 1422 locations
RECRUITINGNCT06712758

Low Intraocular Pressure Cataract Surgery With Zeiss Quatera in Glaucoma Patients

You were selected to participate in this observational study because you suffer from glaucoma and cataracts. For the cataract you will have cataract surgery. This study will not...

Sponsor: Visionair OogzorgEnrolling: 101 location
RECRUITINGNCT05874258

Glaucoma Rehabilitation Using ElectricAI Transcranial Stimulation (GREAT) - Randomized Controlled Trial Using Combined...

Glaucoma is a complex disease that can result in progressive vision loss. It is the second leading cause of blindness, accounting for 23% of permanent blindness in Hong Kong....

Sponsor: The Hong Kong Polytechnic UniversityEnrolling: 1441 location
RECRUITINGNCT02959242

Dresden Glaucoma and Treatment Study (DGTS)

To assure the quality of follow-up and treatment, data of glaucoma patients are stored and evaluated after anonymisation.

Sponsor: Technische Universität DresdenEnrolling: 100001 location
RECRUITINGNCT06057051

Glaukos® iStent Infinite Trabecular Micro-Bypass System in Subjects With Mild to Moderate Primary Open-angle Glaucoma

Prospective, multicenter, single-arm study of the iStent infinite in adult pseudophakic or phakic subjects with mild to moderate primary open angle glaucoma who have not failed...

Sponsor: Glaukos CorporationEnrolling: 2451 location
RECRUITINGNCT05500469

Endothelial Cell Loss in Pseudophakic Patients Receiving a Paul Glaucoma Drainage Device With Its Tube Inserted in the...

Rationale: Glaucoma is a group of diseases characterized by progressive neuropathy of the optic nerve associated with visual field loss. Current glaucoma management aims to...

Sponsor: Oogziekenhuis RotterdamEnrolling: 2001 location
RECRUITINGNCT07298356

Automated Applanation Tonometry - Updated

Goldmann Applanation Tonometry (GAT) is considered the clinical gold standard for eye pressure measurements and yet it is known to be a subjective measurement with limited...

Sponsor: Duke UniversityEnrolling: 2001 location
RECRUITINGNCT07135570

"My Eyes, My Light": Amar Chokh, Amar Alo

Eye disease affects 2.2 billion people globally, which in turn adversely affects schooling, economic productivity, and participation in social life. The primary conditions...

Sponsor: Data Yakka, Inc.Enrolling: 200001 location
RECRUITINGNCT06492538

Biometric Changes After Intervention of Anterior Chamber Angle : an Observational Study

The drainage angle in the anterior chamber of the eye mediates the outflow of aqueous humor, and pathological changes here can lead to high intraocular pressure and glaucoma....

Sponsor: Zhongshan Ophthalmic Center, Sun Yat-sen UniversityEnrolling: 3001 location
RECRUITINGNCT00286637

Novel Glaucoma Diagnostics

The purpose of this research is to evaluate novel technologies for the assessment of ocular structure and function, including the scanning device called Optical Coherence...

Sponsor: Wills EyeEnrolling: 50001 location
RECRUITINGNCT06976034

oCular Examination at Cell RESolution With Optical TransmissionTomography

Understanding the pathogenesis of eye diseases has benefited greatly from recent advances in ophthalmic imaging. However, current clinical imaging systems, such as optical...

Sponsor: Centre Hospitalier National d'Ophtalmologie des Quinze-VingtsEnrolling: 3001 location
RECRUITINGNCT05844384

Nanodropper Use in Primary Open-Angle Glaucoma Patients: A Non-Inferiority Trial

This randomized, single-masked, crossover, non-inferiority trial aims to evaluate the safety and efficacy of Nanodropper-mediated microdrops of ocular hypotensive topical...

Sponsor: 59th Medical WingEnrolling: 301 location
RECRUITINGEarly Phase 1NCT06593405

The Role of Occupational Therapy for Improving Medication Management for Persons With AMD, DR and Glaucoma

The goal of this clinical trial is to learn if education about additional task lighting, enhanced contrast, enlarged print instructions, smart apps and organizational strategies...

Sponsor: MCPHS UniversityEnrolling: 501 location
RECRUITINGNCT06246136

Comparative Effectiveness and Safety of ELIOS in Patients With Open-Angle Glaucoma Undergoing Cataract Surgery

The primary study objective is to compare the effectiveness of the combination of phacoemulsification with intraocular lens implant with ELIOS or competitor device in reducing IOP...

Sponsor: Elios Vision, Inc.Enrolling: 19416 locations
RECRUITINGPhase 1NCT07290244

Evaluating ER-100 for Safety in People With Glaucoma or Non-Arteritic Anterior Ischemic Optic Neuropathy (Optic Nerve...

The goal of this clinical trial is to evaluate the safety and tolerability of a single dose of ER-100 in adults with optic nerve conditions, specifically Open Angle Glaucoma (OAG)...

Sponsor: Life Biosciences Inc.Enrolling: 182 locations
RECRUITINGNCT07206628

Real-world Study to Assess Adherence to IOP Lowering Therapy in Glaucoma Patients Using CONNECTDROP®

The goal of this real-life, national, multicentre, prospective clinical investigation is to describe the adherence rate over time in patients with glaucoma already treated with...

Sponsor: Laboratoires TheaEnrolling: 20017 locations
RECRUITINGPhase 3NCT07335211

Efficacy and Safety of HUC3-637 in Patients With Primary Open Angle Glaucoma or Ocular Hypertension

A multicenter, randomized, single-blind, active controlled, phase III clinical trial to evaluate the efficacy and safety of HUC3-637 in patients with primary open angle glaucoma...

Sponsor: Huons Co., Ltd.Enrolling: 2061 location
RECRUITINGPhase 2 / Phase 3NCT07354516

Study of QLS-111-FDC in Open-Angle Glaucoma or Ocular Hypertension

Firecrest study is evaluating the intraocular pressure (IOP)-lowering effect, safety, and tolerability of Qlaris' preservative free \[PF\], fixed-dose combination \[FDC\]...

Sponsor: Qlaris Bio, Inc.Enrolling: 601 location
RECRUITINGNCT05370287

Adaptive Optics Retinal Imaging

The objective of the study is to collect and assess adaptive optics (AO) retinal images from human subjects in support of projects to demonstrate, advance, and enhance clinical...

Sponsor: Food and Drug Administration (FDA)Enrolling: 801 location
RECRUITINGNCT06691555

Long-term Safety and Efficacy of a Modified Suprachoroidal Silicone Tube (SST) Shunt

The goal of this observational study is to evaluate the long-term safety and efficacy of a modified suprachoroidal silicone tube (SST) shunt in treating patients with primary...

Sponsor: Davinci LTDEnrolling: 661 location
RECRUITINGNCT05801471

Clinical Evaluation of Visual Field Change in Glaucoma: an Assessment of Different Models of Progression

The purpose of this observational study is to collect over time a series of data in patients with glaucoma in order to evaluate different approaches in defining the progression of...

Sponsor: Centervue SpAEnrolling: 2002 locations
RECRUITINGNCT06289491

A Trial of Hydrus Microstent Versus Goniotomy

The goal of this clinical trial is to evaluate the comparative efficacy and safety of Hydrus Microstent, incisional goniotomy, and excisional goniotomy when combined with cataract...

Sponsor: Massachusetts Eye and Ear InfirmaryEnrolling: 2431 location
RECRUITINGNCT05563623

The Beijing Angle Closure Progression Study

The Beijing angle closure progression study (BAPS) aims to explore the 5-year incidence of PACS progressing to PAC or PACG and to determine the possible risk factors of disease...

Sponsor: Peking University People's HospitalEnrolling: 8251 location
RECRUITINGNCT06682962

Transcorneal Electrical Stimulation for the Treatment of Visual Field Defects in Patients With Open-Angle Glaucoma

Glaucoma is a progressive optic neuropathy with retinal ganglion cell loss which leads to visual field loss. Open-angle glaucoma is the most common form of glaucoma. The aim of...

Sponsor: Okuvision GmbHEnrolling: 501 location
RECRUITINGPhase 1 / Phase 2NCT05180994

Topical Infliximab in Eyes With Penetrating Keratoplasty

Penetrating keratoplasty is a cornea surgery involving several inflammatory complications, of which the most important is glaucoma. Researchers wish to determine whether it is...

Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)Enrolling: 501 location
RECRUITINGNCT05753137

Acupuncture as Adjuvant Therapy for Glaucoma - Protocol for a Randomized Controlled Trial

This clinical trial used acupuncture as an adjunctive treatment for glaucoma patients. A randomized, controlled trial involving 50 subjects will be conducted and observed for 12...

Sponsor: China Medical University HospitalEnrolling: 501 location
RECRUITINGNCT06760169

Efficacy and Safety of the ELIOS Laser in Combined Cataract and Glaucoma Surgery

Glaucoma is an irreversible optic neuropathy. It is the second most common cause of blindness worldwide. Glaucoma can be treated with topical medications (eye drops), laser or...

Sponsor: Hôpital Privé de la BaieEnrolling: 461 location
RECRUITINGNCT07243665

Glaucoma Screening Using Artificial Intelligence Assisted Clinical Model in Singapore's Diabetic Eye Screening Program

Glaucoma is major cause of irreversible blindness and is characterized by optic nerve damage and visual field loss. Screening for glaucoma is challenging due to lack of a simple,...

Sponsor: Singapore Eye Research InstituteEnrolling: 10401 location
RECRUITINGPhase 1NCT06964061

Evaluate Efficacy, Safety, Tolerability and Biodegradation of PA5346 Ocular Implant in Patients With Open-Angle...

The goal of this clinical study is to learn how effective and safe is a single administration of PA5346 Ocular Implant for the reduction of intraocular pressure in adult patients...

Sponsor: PolyActiva Pty LtdEnrolling: 123 locations
RECRUITINGNCT03921931

Retinal Photoreceptor Outer Segment Length Before and After Light Stimulation - a Pilot Study

It has been shown that reactions of human retinal photoreceptors to a light stimulus can be measured with custom-made, research prototype optical coherence tomography (OCT)...

Sponsor: Medical University of ViennaEnrolling: 351 location
RECRUITINGPhase 3NCT05401357

Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% and LUMIGAN® in the...

This is a randomized, double-blind, two-treatment, single-period, parallel design, multiple dose at multiple clinical trial sites designed to demonstrate bioequivalence with...

Sponsor: Amneal Pharmaceuticals, LLCEnrolling: 1689 locations
RECRUITINGNCT05150197

Virtual Reality Visual Field Testing as an Alternative in Childhood Eye Disease

The purpose of this study is to test a new way of measuring the peripheral vision (called a visual field test) using a device which can be worn as goggles rather than being a...

Sponsor: Duke UniversityEnrolling: 10001 location
RECRUITINGNCT02157025

A More Engaging Visual Field Test to Increase Use and Reliability in Pediatrics

The majority of young children do not think that visual field (VF) testing of peripheral vision is similar to a game; therefore, it is not surprising that they have difficulty...

Sponsor: Nova Southeastern UniversityEnrolling: 201 location
RECRUITINGNCT05039684

Inflammatory Biomarkers in Ocular Surface in Primary Open Angle Glaucoma or Ocular Hypertension Under Topical...

Glaucoma is a chronic optic neuropathy whose main modifiable risk factor is an abnormally elevated intraocular pressure. The aim of glaucoma treatment is to slow the progression...

Sponsor: Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBAEnrolling: 401 location
RECRUITINGNCT07147647

Direct Selective Laser Trabeculoplasty (DSLT) for Reducing Eye Pressure in Non-Caucasian Patients With Open Angle...

The goal of this clinical trial is to to evaluate how well Direct Selective Laser Trabeculoplasty (DSLT) lowers eye pressure in eyes of adult, non-Caucasian participants with...

Sponsor: Select Eye CareEnrolling: 601 location
RECRUITINGNCT06844292

Evaluation of Microinvasive Glaucoma Surgery: MINIject® Versus Hydrus® Microstent in Combination With Cataract Surgery

The study aims to investigate postoperative outcomes after two different MIGS implants (MINIject or Hydrus) in combination with cataract surgery for patients with glaucoma.

Sponsor: Medical University of GrazEnrolling: 1521 location
RECRUITINGNCT06963684

Glaucoma Laser Assessment of Stability and Sustainability

The GLASS Study is designed to help researchers learn whether repeating a non-invasive laser treatment called DSLT (Direct Selective Laser Trabeculoplasty) can better control eye...

Sponsor: Twin Cities Eye ConsultantsEnrolling: 481 location
RECRUITINGNCT07454447

UBM Evaluation After Combined Deep Sclerectomy With Trabeculotomy in Primary Open Angle Glaucoma

Primary open-angle glaucoma is a chronic optic neuropathy that often requires surgical intervention when medical treatment fails. Deep sclerectomy is a non-penetrating glaucoma...

Sponsor: Minia University HospitalEnrolling: 301 location
RECRUITINGNCT06933836

DSLT Performance in Treatment-naïve Patients With Newly Diagnosed Open Angle Glaucoma

DSLT demonstrates a ≥ 20% reduction of IOP from pre-treatment baseline in POAG patients naïve of previous glaucoma treatment at 12 months.

Sponsor: Barnet Dulaney Perkins Eye CentersEnrolling: 551 location
RECRUITINGNCT07152132

SCTSC Versus Trabeculectomy in Medically Uncontrolled Open-Angle Glaucoma in Pseudophakic Patients

cyclodiode versus trabeculectomy with MMC in pseudophakic patients.

Sponsor: Minia UniversityEnrolling: 501 location
RECRUITINGPhase 3NCT04967989

Clarifying the Optimal Application of SLT Therapy Trial

The goal of this study is to understand if SLT performed at low energy is as effective as SLT performed at standard energy, and also to see if repeating SLT at low energy once a...

Sponsor: University of PittsburghEnrolling: 79020 locations
RECRUITINGPhase 1 / Phase 2NCT05694858

Transdermal Microneedle Lignocaine Delivery Versus EMLA Patch for Topical Analgesia Before Venepuncture Procedure To...

Microneedle (MN) is a mimic of a hypodermic needle, composed of hundreds of micron-sized, out-of-plane protrusions, typically arranged in arrays on a patch that can be applied...

Sponsor: Universiti Kebangsaan Malaysia Medical CentreEnrolling: 1541 location
RECRUITINGNCT02084745

Timing of Glaucoma Drainage Device With Boston Keratoprosthesis

Boston keratoprosthesis (KPro) is a piece of specialized plastic that replace sick cornea (transparent structure at the front of the eye) in patients who have failed or those who...

Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)Enrolling: 401 location
RECRUITINGPhase 3NCT05710198

Efficacy of Citicoline Eye Drops 2% on Visual Field Preservation in Patients With Open Angle Glaucoma

To evaluate the efficacy of citicoline eye drops 2% in reducing visual field deterioration in patients with progressing OAG treated according to best clinical practice. Secondary...

Sponsor: Omikron Italia S.r.l.Enrolling: 10001 location
RECRUITINGNCT06124521

Community Based Treatment for (ComBaT) Glaucoma

The purpose of this research is to evaluate if intervention and education can change the behavior of someone's willingness to see an eye care provider to prevent blindness and...

Sponsor: University of MichiganEnrolling: 602 locations
RECRUITINGNCT06077253

Danish Angle Closure Prevention Trial

To determine whether primary angle closure suspects (PACS) in a Caucasian population benefit from prophylactic laser iridotomy.

Sponsor: University of AarhusEnrolling: 2425 locations
RECRUITINGPhase 4NCT06883123

Efficacy of Simbrinza and Rocklatan vs Cosopt and Latanoprost

A randomized, multi-site, parallel-group, prospective study of patients who are adults with a diagnosis of mild to moderate open-angle glaucoma (OAG), currently on an on-label use...

Sponsor: Prairie Eye CenterEnrolling: 701 location
RECRUITINGNCT07149740

Data Gathering for A10900

The objective of this study is to gather Optical Coherence Tomography (OCT) data on normal and diseased eyes

Sponsor: Optos, PLCEnrolling: 1804 locations
RECRUITINGNCT07063537

Feasibility, Accuracy, and Reproducibility of Virtual Reality Visual Field Testing in Patients With Glaucoma

The goal of this clinical trial is to evaluate the feasibility of using virtual reality based visual field testing to monitor glaucoma in a clinical setting. This will be done...

Sponsor: Nova Scotia Health AuthorityEnrolling: 601 location
RECRUITINGNCT05340647

NorMIGS - a Study of Micro-invasive Glaucoma Surgery

NorMIGS is a non-randomized clinical study of intraocular pressure lowering effect and complications after Preserflo microshunt implantation versus other types of glaucoma...

Sponsor: Oslo University HospitalEnrolling: 1001 location

Showing 50 of 108 trials.Search all Glaucoma trials

Frequently Asked Questions

There are currently 108 clinical trials for Glaucoma, with 108 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.

To join a clinical trial for Glaucoma, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.

Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 8 Phase 3 trials for Glaucoma, representing treatments closest to potential FDA approval.

Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.

Sources: ClinicalTrials.gov, FDA
Last updated:

Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice — always talk to your doctor about clinical trial participation.